Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Upadacitinib improves clinical outcomes of patients with rheumatoid arthritis

Posted by on Sep 10, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of upadacitinib (Rinvoq) in patients with rheumatoid arthritis (RA) who progressed after methotrexate (Otrexup). Researchers suggested that upadacitinib improved clinical and functional outcomes in these patients. Some background RA is an autoimmune disorder which occurs when the...

Read More

How effective is filgotinib in the treatment of unresponsive rheumatoid arthritis?

Posted by on Aug 28, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the effectiveness of filgotinib (FGB) in patients with unresponsive rheumatoid arthritis (RA). They found that FGB improves RA management at 12 weeks.  Some background Rheumatoid arthritis (RA) is a chronic condition. Inflammation leads to painful swelling in the joints. RA is treated with...

Read More

Leflunomide – a review of its use in the treatment of juvenile idiopathic arthritis

Posted by on Aug 21, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the use of leflunomide (Arava) in juvenile idiopathic arthritis (JIA).   They found that this medication may be useful in managing JIA in patients resistant or intolerant to methotrexate.  Some background Juvenile idiopathic arthritis (JIA) is caused by inflammation in the joints. JIA is...

Read More

Remission with etanercept – what degree of remission predicts long-term success?

Posted by on Aug 14, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if initial remission can predict long-term remission (LTR) after etanercept (Enbrel) treatment.  They found that LTR is more likely if strict disease control is achieved before etanercept withdrawal Some background Rheumatoid arthritis (RA) is a long-term condition. Disease-modifying anti-rheumatic...

Read More

Long-term treatment with baricitinib – an analysis of the long-term safety and effectiveness

Posted by on Aug 2, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of long-term treatment with baricitinib (Olumiant) in rheumatoid arthritis (RA).   They found that this drug was effective and well tolerated alone or in combination with methotrexate (MTX).  Some background Rheumatoid arthritis (RA) is a long-term...

Read More

Searching for patients with rheumatoid arthritis to test a treatment combination

Posted by on Jul 29, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This phase 3 trial will investigate the effectiveness of GSK3196165 combined with methotrexate (MTX). The main outcome will be the number of patients achieving a 20% improvement in symptoms (ACR20). The details Rheumatoid arthritis (RA) is a condition caused by inflammation. Drugs that reduce inflammation are used to treat RA....

Read More

Abatacept – what is the safety profile in rheumatoid arthritis treatment?

Posted by on Jul 18, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety of abatacept (Orencia) compared to other disease-modifying anti-rheumatic drugs (DMARDs).  They found that this treatment was well tolerated and had a similar safety profile to other DMARDs. Some background Rheumatoid arthritis (RA) is a chronic condition. It is caused by painful swelling...

Read More

Orofacial symptoms and dentofacial deformities in patients with juvenile idiopathic arthritis

Posted by on Jun 30, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the rates of orofacial symptoms (OFS) and dentofacial deformities (DFD) in patients with juvenile idiopathic arthritis (JIA).  They found that OFS and DFD rates were high in JIA. Some background Juvenile idiopathic arthritis (JIA) is an inflammatory condition that affects children. JIA leads to painful...

Read More